Is Daily Step Count worth prioritizing?

At least seven independent dose-response meta-analyses published between 2021 and 2024, including a synthesis of 15 international cohorts in The Lancet Public Health and an umbrella review, converge on a consistent pattern: higher daily step counts are associated with progressively lower all-cause and cardiovascular mortality risk, with the steepest risk reduction typically occurring between roughly 4,000 and 8,000 steps per day and more gradual additional benefit beyond that — meaning meaningful benefit occurs well below the popular 10,000-step target, which appears to have originated from a 1960s Japanese marketing campaign rather than research. Weighing that against the numbers, Daily Step Count is a strong candidate to prioritize — it combines strong evidence (88/100) with a high estimated impact on longevity (80/100).